CD8A and breast cancer: Consequently, SAPConpromoted an immunogenic tumor microenvironment characterized by increasedfrequency of activated macrophages and dendritic cells and improvedinfiltration of CD8+ T cells, resulting in inhibition oftumor growth, prolonged survival, and enhanced response to anti-PD-1immune checkpoint blockade in orthotopic breast cancer models.